Joy as NICE changes tack on first NHS vitiligo treatment NHS patients in England with vitiligo will soon be able to access Incyte's Opzelura, the first drug shown to reverse the skin-lightening disorder.

#NICE #NHS #vitiligo #vitiligotreatment #NICEnews #skinlighteningdisorder #NICEapprovedtreatment #Reimbursement #Incyte #JAKinhibitorcream #Opzelura #ruxolitinib #facialvitiligo #JAKsignallingpathway #TheVitiligoSociety #oralJAKinhibitors #skindisorder #dermatology
zurl.co/dZyqZ